卒中病因影响急性卒中血管内治疗的效果
基于德国卒中登记-血管内治疗(GSR-ET)2589例大血管闭塞患者,比较心源性栓塞与非心源性栓塞的血管内治疗疗效。心源性栓塞者成功再灌注率更高(85.6% vs 81.0%,P=0.002),出院和90天功能结局更优(调整OR分别为1.61和1.29),再灌注介导了出院时47%的病因效应。
要点
- 心源性栓塞大血管闭塞血管内治疗后成功再灌注率更高(85.6% vs 81.0%)。
- 心源性栓塞与出院及90天功能结局更优独立相关。
- 再灌注解释了病因对出院功能结局效应的47%。
核心结论
- 心源性栓塞大血管闭塞的血管内治疗疗效高于非心源性栓塞。
研究设计与样本
- 基于德国卒中登记-血管内治疗(GSR-ET)2589例大血管闭塞患者的比较研究。
主要发现
- 心源性栓塞成功再灌注率85.6%,非心源性栓塞81.0%(P=0.002)。
- 单次取栓完全再灌注率心源性栓塞45.7%,非心源性栓塞38.1%(P<0.001)。
- 心源性栓塞出院功能结局调整OR 1.61(95%CI 1.37-1.88),90天调整OR 1.29(95%CI 1.09-1.53)。
- 再灌注解释了病因对出院功能结局效应的47%。
临床怎么用
- 对心源性栓塞大血管闭塞患者,血管内治疗可能获得更高的再灌注率和更好的功能结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Stroke etiology drives thrombus composition. We thus hypothesized that endovascular treatment shows different efficacy in cardioembolic versus noncardioembolic large-vessel occlusions (LVOs). Methods- Procedural characteristics, grade of reperfusion, and functional outcome at discharge and 90 days were compared between patients with cardioembolic versus noncardioembolic LVO from the GSR-ET (German Stroke Registry-Endovascular Treatment; n=2589). To determine associations with functional outcome, adjusted odds ratios and 95% CIs were calculated using ordinal multivariable logistic regression models adjusting for potential baseline confounder variables. Results- Endovascular treatment of cardioembolic LVO had a higher rate of successful reperfusion (85.6% versus 81.0%; P=0.002) and a higher rate of complete reperfusion after a single thrombectomy pass (45.7% versus 38.1%; P<0.001) compared with noncardioembolic LVO. Cardioembolic LVO was associated with better functional outcome at discharge (adjusted odds ratio, 1.61 [95% CI, 1.37-1.88]) and 90 days (adjusted odds ratio, 1.29 [95% CI, 1.09-1.53]). In mediation analysis, reperfusion explained 47% of the effect of etiology on functional outcome at discharge. Conclusions- These results provide evidence for higher efficacy of endovascular treatment in cardioembolic LVO compared with noncardioembolic LVO.
引用
- Tiedt S, Herzberg M, Küpper C, et al. Stroke Etiology Modifies the Effect of Endovascular Treatment in Acute Stroke. Stroke. 2019. PMID: 31847752. doi:10.1161/STROKEAHA.119.028383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。